Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes

被引:25
作者
Renwick, AB
Lavignette, G
Worboys, PD
Williams, B
Surry, D
Lewis, DFV
Price, RJ
Lake, BG
Evans, DC
机构
[1] TNO BIBRA Int Ltd, Carshalton SM5 4DS, Surrey, England
[2] Univ Bourgogne, ENS BANA, F-21100 Dijon, France
[3] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[4] Univ Surrey, Sch Biomed & Life Sci, Guildford GU2 5XH, Surrey, England
[5] Merck & Co Inc, Drug Metab, Rahway, NJ 07065 USA
关键词
D O I
10.1080/00498250110074063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aim of this study was to evaluate a number of derivatives of 7-hydroxy-4-trifluoromethylcoumarin (HFC) and 7-benzyloxyquinoline (7BQ) as novel fluorescent substrates for monitoring rat hepatic cytochrome P450 (CYP) enzyme specificity in a 96-well plate format. The HFC derivatives examined comprised 7-benzyloxy-4-trifluoromethylcoumarin (BFC), 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (BFBFC), 3,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (BTBFC), 2-(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin (2TFBFC), 3-(trifluoromethyl) -7-benzyloxy-4-trifluoromethylcournarin (3TFBFC) and 3-(trifluoromethoxy)-7-benzyloxy-4-trifluoromethylcoumarin (3TFMeOBFC). 2. The CYP specificity of the fluorescent probe substrates was examined using characterized liver microsomes from male Sprague-Dawley rats treated with beta -naphthoflavone (BNF), sodium phenobarbitone (NaPB), isoniazid, pregnenolone-16 alpha -carbonitrile (PCN), dexamethasone (DEX) and methylclofenapate to induce CYP1A, CYP2B, CYP2E, CYP3A, CYP3A and CYP4A forms, respectively. Studies were also performed with microsomes from baculovirus-infected insect cells containing rat cDNA-expressed CYP1A1, CYP1A2, CYP2B1, CYP3A1 and CYP3A2. 3. BFC metabolism was most markedly induced by BNF and NaPB, whereas BFBFC metabolism was most markedly induced by PCN and DEX and BTBFC was not metabolized by rat liver microsomes. BFC was a high-affinity substrate for cDNA-expressed CYP1A1 and CYP2B1, whereas BFBFC exhibited a high affinity for CYP3A1 and CYP3A2. 4. The metabolism of 2TFBFC and 3TFBFC was induced by NaPB, PCN and DEX. 3TFBFC was a relatively specific substrate for cDNA-expressed CYP2B1, whereas 2TFBFC could be metabolized by CYP2B1, CYP3A1 and CYP3A2. 5. 3TFMeOBFC metabolism was markedly induced by BNF treatment and 3TFMeOBFC was extensively metabolized by cDNA-expressed CYP1A1. 6. The metabolism of 7BQ to 7-hydroxyquinoline was induced by treatment with PCN and DEX. 7BQ was a substrate for cDNA-expressed CYP3A2 and to a lesser extent for CYP3A1. 7. In summary, some of the HFC derivatives studied and 7BQ are useful fluorescent probe substrates for rat CYP enzymes. BFC appears to be a probe for CYP1A and CYP2B, 2TFBFC for CYP2B and CYP3A and 3TFBFC for CYP2B. While 3TFMeOBFC appears to be a relatively specific probe for CYP1A1, both BFBFC and 7BQ are good probes for the induction of CYP3A.
引用
收藏
页码:861 / 878
页数:18
相关论文
共 41 条
[1]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[2]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[3]   A HIGHLY SENSITIVE TOOL FOR THE ASSAY OF CYTOCHROME-P450 ENZYME-ACTIVITY IN RAT, DOG AND MAN - DIRECT FLUORESCENCE MONITORING OF THE DEETHYLATION OF 7-ETHOXY-4-TRIFLUOROMETHYLCOUMARIN [J].
BUTERS, JTM ;
SCHILLER, CD ;
CHOU, RC .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (09) :1577-1584
[4]   Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe [J].
Chauret, N ;
Tremblay, N ;
Lackman, RL ;
Gauthier, JY ;
Silva, JM ;
Marois, J ;
Yergey, JA ;
Nicoll-Griffith, DA .
ANALYTICAL BIOCHEMISTRY, 1999, 276 (02) :215-226
[5]   In vitro assessment of human cytochrome P450 [J].
Clarke, SE .
XENOBIOTICA, 1998, 28 (12) :1167-1202
[7]  
Crespi CL, 1998, MED CHEM RES, V8, P457
[8]   Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450 [J].
Crespi, CL ;
Miller, VP ;
Penman, BW .
ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :188-190
[9]   A DIRECT, HIGHLY SENSITIVE ASSAY FOR CYTOCHROME-P-450 CATALYZED O-DEETHYLATION USING A NOVEL COUMARIN ANALOG [J].
DELUCA, JG ;
DYSART, GR ;
RASNICK, D ;
BRADLEY, MO .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (09) :1731-1739
[10]   A MICROASSAY FOR MEASURING CYTOCHROME-P450IA1 AND CYTOCHROME-P450IIB1 ACTIVITIES IN INTACT HUMAN AND RAT HEPATOCYTES CULTURED ON 96-WELL PLATES [J].
DONATO, MT ;
GOMEZLECHON, MJ ;
CASTELL, JV .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (01) :29-33